Germany | Spain | Italy | |
---|---|---|---|
Baseline | |||
Presence | 24,427 | 1,908 | 4,877 |
Absence | 5,341 | 2,683 | 5,956 |
Type 2 diabetes; including only incident type 2 diabetes | |||
Presence | 8,753 | 1,050 | 1,775 |
Absence | 3,382 | 2,115 | 3,876 |
Proportion treated; assume 58% hypertensive subjects were treated in Spain | |||
Presence | NA | 2,010 | NA |
Absence | NA | 3,058 | NA |
Continuation rate; vary by 20% above/below the mean | |||
+ 20% Presence | 24,418 | 1,913 | 4,895 |
+ 20% Absence | 5,357 | 2,707 | 6,035 |
- 20% Presence | 24,406 | 1,898 | 4,850 |
- 20% Absence | 5,302 | 2,635 | 5,831 |
Costs; vary by 20% above/below the mean Drug costs | |||
+ 20% Presence | 24,553 | 1,928 | 4,929 |
+ 20% Absence | 5,423 | 4,329 | 6,147 |
- 20% Presence | 24,247 | 1,886 | 4,825 |
- 20% Absence | 5,224 | 2,603 | 5,762 |
CVD costs | |||
+ 20% Presence | 25,481 | 2,049 | 5,041 |
+ 20% Absence | 5,682 | 2,934 | 6,276 |
- 20% Presence | 23,373 | 1,769 | 4,714 |
- 20% Absence | 5,000 | 2,431 | 5,637 |
Type 2 diabetes costs | |||
+ 20% Presence | 27,743 | 2,102 | 5,573 |
+ 20% Absence | 5,735 | 2,803 | 6,392 |
- 20% Presence | 21,112 | 1,715 | 4,183 |
- 20% Absence | 4,948 | 2,564 | 5,521 |